It has been suggested that the presence of T to G single nucleotide polymorphism (SNP) (SNP309; rs2279744) in the promoter region of MDM2 [20] may increase the MDM2-associated malignant activity and contribute to the development of neuroblastoma [21]. Here, MDM2 is linked to neuroblastoma.